Check out our HIV coverage
Key clinical point: Early initiation of antiretroviral therapy in infants is associated with better outcomes.Major finding: Longer time to viral rebound was associated with higher baseline CD4, higher birth weight, and viral suppression within 40 weeks of starting ART.Study details: Analysis of outcomes in 183 infants with HIV infection in the CHER trial.Disclosures: The study was funded by the U.S. National Institutes of Health. Dr. Chan reported having nothing to disclose.Source: Violari A et al. CROI 2018, Abstract 137.
FROM CROI 2018
The study was the U.S. National Institutes of Health. Dr. Chan reported having nothing to disclose.
SOURCE: Violari A et al. CROI 2018, Abstract 137
November 12, 2018
October 29, 2018
October 1, 2018
September 17, 2018
We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.